BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8093189)

  • 1. "Molecular genetic analysis of the WT1 gene in patients suspected to have the Denys-Drash syndrome".
    Coppes MJ; Clericuzio CL
    Med Pediatr Oncol; 1994; 23(4):390. PubMed ID: 8093189
    [No Abstract]   [Full Text] [Related]  

  • 2. Denys-Drash syndrome: relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1.
    Coppes MJ; Huff V; Pelletier J
    J Pediatr; 1993 Nov; 123(5):673-8. PubMed ID: 8229473
    [No Abstract]   [Full Text] [Related]  

  • 3. A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys-Drash syndrome.
    Ogawa O; Eccles MR; Yun K; Mueller RF; Holdaway MD; Reeve AE
    Hum Mol Genet; 1993 Feb; 2(2):203-4. PubMed ID: 8098976
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel mutation of the WT1 gene (a tumor suppressor gene for Wilms' tumor) in a patient with Denys-Drash syndrome.
    Sakai A; Tadokoro K; Yanagisawa H; Nagafuchi S; Hoshikawa N; Suzuki T; Kohsaka T; Hasegawa T; Nakahori Y; Yamada M
    Hum Mol Genet; 1993 Nov; 2(11):1969-70. PubMed ID: 8281164
    [No Abstract]   [Full Text] [Related]  

  • 5. A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome.
    Akasaka Y; Kikuchi H; Nagai T; Hiraoka N; Kato S; Hata J
    FEBS Lett; 1993 Feb; 317(1-2):39-43. PubMed ID: 8381368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetics of Wilms' tumour.
    Tay JS
    J Paediatr Child Health; 1995 Oct; 31(5):379-83. PubMed ID: 8554853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel WT1 gene mutation p.H377N associated to Denys-Drash syndrome.
    Guaragna MS; Soardi FC; Assumpção JG; Zambaldi Lde J; Cardinalli IA; Yunes JA; de Mello MP; Brandalise SR; Aguiar Sdos S
    J Pediatr Hematol Oncol; 2010 Aug; 32(6):486-8. PubMed ID: 20562648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral Wilms tumor in a boy with severe hypospadias and cryptochidism due to a heterozygous mutation in the WT1 gene.
    Köhler B; Schumacher V; Schulte-Overberg U; Biewald W; Lennert T; l'Allemand D; Royer-Pokora B; Grüters A
    Pediatr Res; 1999 Feb; 45(2):187-90. PubMed ID: 10022588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further evidence that imbalance of WT1 isoforms may be involved in Denys-Drash syndrome.
    König A; Jakubiczka S; Wieacker P; Schlösser HW; Gessler M
    Hum Mol Genet; 1993 Nov; 2(11):1967-8. PubMed ID: 8281163
    [No Abstract]   [Full Text] [Related]  

  • 11. The Drash syndrome revisited: diagnosis and follow-up.
    Friedman AL; Finlay JL
    Am J Med Genet Suppl; 1987; 3():293-6. PubMed ID: 2835969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inherited WT1 mutation in Denys-Drash syndrome.
    Coppes MJ; Liefers GJ; Higuchi M; Zinn AB; Balfe JW; Williams BR
    Cancer Res; 1992 Nov; 52(21):6125-8. PubMed ID: 1327525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.
    Pelletier J; Bruening W; Kashtan CE; Mauer SM; Manivel JC; Striegel JE; Houghton DC; Junien C; Habib R; Fouser L
    Cell; 1991 Oct; 67(2):437-47. PubMed ID: 1655284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A newly identified exonic mutation of the WT1 gene in a patient with Denys-Drash syndrome.
    Tsuda M; Sakiyama T; Owada M; Chiba Y
    Acta Paediatr Jpn; 1996 Jun; 38(3):265-6. PubMed ID: 8741319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WT1 mutations in patients with Denys-Drash syndrome: a novel mutation in exon 8 and paternal allele origin.
    Nordenskjöld A; Friedman E; Anvret M
    Hum Genet; 1994 Feb; 93(2):115-20. PubMed ID: 8112732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Denys-Drash syndrome].
    Kohsaka T; Tagawa M; Yamada M
    Nihon Rinsho; 2006 Sep; Suppl 3():457-64. PubMed ID: 17022587
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glomerulopathy in Denys-Drash syndrome. Case report of a model disease].
    Stallmach T; Neuhaus TJ; Kösters R; Hailemariam S
    Pathologe; 1998 May; 19(3):230-4. PubMed ID: 9648150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline WT1 mutations in Wilms' tumor patients: preliminary results.
    Li FP; Breslow NE; Morgan JM; Ghahremani M; Miller GA; Grundy PE; Green DM; Diller LR; Pelletier J
    Med Pediatr Oncol; 1996 Nov; 27(5):404-7. PubMed ID: 8827066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Denys-Drash syndrome.
    Mueller RF
    J Med Genet; 1994 Jun; 31(6):471-7. PubMed ID: 8071974
    [No Abstract]   [Full Text] [Related]  

  • 20. The human sex-determining gene SRY is a direct target of WT1.
    Hossain A; Saunders GF
    J Biol Chem; 2001 May; 276(20):16817-23. PubMed ID: 11278460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.